283 results
10-Q
2022 Q3
PRPO
Precipio Inc
10 Nov 22
Quarterly report
4:02pm
the equipment to the customer. Finance lease ROU assets and finance lease liabilities are recognized at the lease commencement date … diagnostic testing equipment from the Company with the transfer of ownership to the customer at the end of the lease term at no additional cost
10-Q
2022 Q2
PRPO
Precipio Inc
11 Aug 22
Quarterly report
4:02pm
to the customer. Finance lease ROU assets and finance lease liabilities are recognized at the lease commencement date, and at the sublease commencement date … with the transfer of ownership to the customer at the end of the lease term at no additional cost. For these contracts, the Company accounts
8-K
EX-99.1
PRPO
Precipio Inc
13 Jun 22
Regulation FD Disclosure
5:09pm
in operating profit (currently one panel only) HemeScreen Benefits Turnaround Time (TAT) Patient Impact Customer Economics HemeScreen delivered benefits … to a large customer in Florida Case Study 6
Page Solution A proprietary media (chemical) used to simultaneously culture multiple types of suspected
10-Q
2022 Q1
PRPO
Precipio Inc
11 May 22
Quarterly report
4:01pm
. For certain customers in the HSRR program, the Company leases diagnostic testing equipment and then subleases the equipment to the customer. Finance lease ROU … equipment from the Company with the transfer of ownership to the customer at the end of the lease term at no additional cost. For these contracts
DEF 14A
PRPO
Precipio Inc
28 Apr 22
Definitive proxy
4:54pm
HemeScreen customers also became a diagnostic services customer. This is the first time we have seen this cross-pollination effect, where … the relationship and quality of our products opened up a discussion to the other side of our business, diagnostic services. We now serve this customer with both
10-K
cw6u8asn559hml4dpdf1
30 Mar 22
Annual report
5:04pm
8-K
EX-99.1
gd4fosm0a5xup5a5zmy
25 Feb 22
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
6:51pm
10-Q
vrvrcic8t n1htp
12 Nov 21
Quarterly report
4:02pm
10-Q
tlt3f3lkdib
12 Aug 21
Quarterly report
4:07pm
8-K
EX-99.1
8e0z9le
28 Jul 21
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
4:41pm
10-Q
4p2olaou
14 May 21
Quarterly report
4:01pm
DEF 14A
zymqpvkn
29 Apr 21
Definitive proxy
4:31pm
424B5
uqq3o68g6jr0cmh
2 Apr 21
Prospectus supplement for primary offering
2:00pm
10-K
m0gm4i8
29 Mar 21
Annual report
4:29pm
10-Q
nlf8muyq5w1
13 Nov 20
Quarterly report
4:01pm
10-Q
egw3b1on zu5k
13 Aug 20
Quarterly report
3:07pm
8-K
EX-99.1
2fx 8ibd524cix
22 Jul 20
Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20
4:00pm
424B3
8i6baacyztu gcc3y6w
7 Jul 20
Prospectus supplement
5:27pm
S-1
k3vez9s m45brtbhhv
26 Jun 20
IPO registration
5:18pm
10-Q
2ewy7f95 pd8m
14 May 20
Quarterly report
4:05pm